Solene__Frost Posted - 3 days ago

😏🚀 MYNZ We know the date of the reverse split (RS) if there will be one, but possibly a Nasdaq extension will be granted. Last time it traded, 50 million and 19 million heavy shorts attacked. Now, it has huge credibility after the TMO partnership and the meeting. The company will decide by November 25th whether or not to do an RS based on Nasdaq's response. Anyway, after the RS, I'm not worried about what happens next. A $210 billion partner TMO signing a deal with a penny stock has never happened before. I will be loading heavy on Monday. This will go to the moon like the DRUG stock recently did. The price target (PT) is $50. The squeeze will be parabolic. $CGEM $PAHC

Kaiser_Villa Posted - 6 days ago

$CGEM $PAHC MYNZ Wow, this is insane news! Don't miss out. The train is leaving the station. Add it to your watchlist to see what happens next. 😏

Thestocktraderhubzee Posted - 1 week ago

$PAHC Barclays Maintains Underweight on Phibro Animal Health, Raises Price Target to $20

Norbvr Posted - 10/31/24

$PAHC https://www.businesswire.com/news/home/20241031903897/en/

PenkeTrading Posted - 1 month ago

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Phibro Animal Health Corporation. Is that bullish or bearish? $PAHC #RsiOverbought #NASDAQ

Terrordomo80 Posted - 1 month ago

$ELAN what a piece of dirt...any half decent co moving up in this mkt over the past 6 months even $PAHC more than doubling in price but not this eternal turd... straight trash..

WeeklyTrader Posted - 1 month ago

How are you feeling about $PAHC's future? RSI: 71.04% 50-day MA: $20.49 200-day MA: $16.12

OldManGrumble Posted - 09/30/24

$PAHC This is one of my favorite agricultural-related plays right now.

antonioelruso Posted - 09/25/24

$PAHC Huge and Long

galett Posted - 2 months ago

$PAHC Looks good

OldManGrumble Posted - 2 months ago

$PAHC Glad I hold some.

vjtweet Posted - 2 months ago

$PAHC that is very bullish looking. Has a small position.

PenkeTrading Posted - 08/30/24

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Phibro Animal Health Corporation. Is that bullish or bearish? $PAHC #PAHC #nasdaq #tradingsignals #technicalanalysis

Thestocktraderhubzee Posted - 08/30/24

$PAHC B of A Securities Maintains Underperform on Phibro Animal Health, Raises Price Target to $15

JackDarwin Posted - 08/29/24

$PAHC Bullish Engulfing Formed With Good Volume.

DonCorleone77 Posted - 08/28/24

$PAHC Phibro Animal Health sees FY25 revenue $1.04B-$1.09B, consensus $1.13B Sees FY25 adjusted EBITDA $118M-$126M vs. $111.2M last year.

DonCorleone77 Posted - 08/28/24

$PAHC Phibro Animal Health reports Q4 EPS 41c, consensus 33c Reports Q4 revenue $273.2M, two estimates $263.2M. "We showed a lot of strength in our 4th quarter performance, with each of our segments growing at a faster year-over-year rate as compared to their first nine months of the year. This was led by our core Animal Health segment which grew at 8% for the quarter, with particular strength in our vaccine and MFA & Other lines," said Jack Bendheim, CEO. "We ended the year on an upswing that we anticipate building upon as we enter our 2025 fiscal year. Our guidance reflects our strong momentum as well as the early fruits of Phibro Forward - a company-wide initiative we have undertaken focused on unlocking additional areas of revenue growth and cost savings. We expect meaningful additional impact from Phibro Forward in the years to come, and, together with the anticipated closing of the Zoetis MFA acquisition in the coming months, believe we are extremely well positioned to grow income faster than our historical levels."

epsguid Posted - 08/28/24

$PAHC reported earnings of $0.41, consensus was $0.34, Earnings Whisper was $0.36 via @eWhispers #whisperbeat http://eps.sh/d/pahc

Stock_Titan Posted - 08/28/24

$PAHC Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance https://www.stocktitan.net/news/PAHC/phibro-animal-health-corporation-reports-fourth-quarter-and-fiscal-ssg27fydykuj.html

fer69 Posted - 08/28/24

$PAHC corrected previous post. No January 2025 available. Sold March 2025 at market value … got $610 dollars premium for $15 calls sold … so basically if exercise I sold at 21.10 … hope it goes down so I’m not force to sell

fer69 Posted - 08/28/24

$PAHC this should go down nicely after earnings today … it just run up a lot from lows …. No matter if ER is great …hedging my position with March 2025 $15 calls sold … average around $11

fer69 Posted - 08/28/24

$PAHC sold deep in the money calls $15 for January … my average is around $11 … I’m bullish still but run out a lot from lows … hedging gains

Doozio Posted - 08/23/24

$pahc chop chop huckleberries 💋. Keep it simple stupid! It’s 🧠⏰

Doozio Posted - 08/23/24

$PAHC 🧠⏰ is NOW n if da huckleberries arrive it will get da $MOMO TTWO during 🧠⏰♾️

Stock_Titan Posted - 3 months ago

$PAHC Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2024 Results https://www.stocktitan.net/news/PAHC/phibro-animal-health-corporation-to-host-webcast-and-conference-call-txiom0rnfiew.html

NVDAMillionaire Posted - 3 months ago

$PAHC Phibro Animal Health Corporation: A Diversified Animal Health and Mineral Nutrition Leader Poised for Growth http://beyondspx.com/2024/08/02/phibro-animal-health-corporation-a-diversified-animal-health-and-mineral-nutrition-leader-poised-for-growth/

jackzhang123 Posted - 4 months ago

$PAHC Phibro Animal Health(PAHC) 2023 and Q3 2024 Financial Analysis, and Stock Valuation https://stockswall.com/phibro-animal-healthpahc-2023-and-q3-2024-financial-analysis-and-stock-valuation/

DonCorleone77 Posted - 4 months ago

$BAX $PAHC "Should Value Investors Buy Baxter International (BAX) Stock?" From Zacks Equity Research Tue, Jul 9, 2024, 10:00 AM EDT: The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks. Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now. One stock to keep an eye on is Baxter International (BAX). BAX is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The stock holds a P/E ratio of 11.44, while its industry has an average P/E of 19.94. Over the past 52 weeks, BAX's Forward P/E has been as high as 15.91 and as low as 10.64, with a median of 13.14. Investors should also note that BAX holds a PEG ratio of 1.73. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. BAX's PEG compares to its industry's average PEG of 1.97. Over the past 52 weeks, BAX's PEG has been as high as 4.33 and as low as 1.63, with a median of 2.26. Value investors also use the P/S ratio. The P/S ratio is is calculated as price divided by sales. This is a prefered metric because revenue can't really be manipulated, so sales are often a truer performance indicator. BAX has a P/S ratio of 1.15. This compares to its industry's average P/S of 1.46. If you're looking for another solid Medical - Products value stock, take a look at Phibro Animal Health (PAHC). PAHC is a # 1 (Strong Buy) stock with a Value score of A. Shares of Phibro Animal Health are currently trading at a forward earnings multiple of 11.81 and a PEG ratio of 4.41 compared to its industry's P/E and PEG ratios of 19.94 and 1.97, respectively. Over the last 12 months, PAHC's P/E has been as high as 15.18, as low as 8.01, with a median of 10.56, and its PEG ratio has been as high as 7.83, as low as 2.19, with a median of 4.40. Phibro Animal Health also has a P/B ratio of 2.53 compared to its industry's price-to-book ratio of 6.77. Over the past year, its P/B ratio has been as high as 2.78, as low as 1.42, with a median of 1.89. These are only a few of the key metrics included in Baxter International and Phibro Animal Health strong Value grade, but they help show that the stocks are likely undervalued right now. When factoring in the strength of its earnings outlook, BAX and PAHC look like impressive value stocks at the moment.

falconfly1 Posted - 4 months ago

$EYEN $ACB and $PAHC and $CPHI and $AMPH What is new and opportunity in $EYEN? The stock is $EYEN. ==> fair value 11.09 1 - Insider bought 1.5 million shares in July and paid 1 Million dollars 2 - Vanguard biggest institution in the world bought 5 million dollars for a call option 3 - First FDA MydCombi selling from April 2024, and they have a contract with Vision Source biggest Private Practice Optometrists in the USA and Canada. Vision Source multi a billion company. 4 - Second FDA's strongest eyedrop sales start the first of August and are expected to generate 15 to 40 million per quarter. 5 - 8 or 9 August earnings call, and it should be good. 6 - MicroPine and MicroLine are unmet need eyedrops for children and the result is coming in Q4 2024..